Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 05/03/24
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewsWire • 04/24/24
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual MeetingGlobeNewsWire • 04/09/24
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 03/26/24
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual MeetingGlobeNewsWire • 03/05/24
Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio ValueSeeking Alpha • 03/04/24